Search Results for "retail"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for retail. Results 31 to 40 of 361 total matches.
Comparison Table: Some Oral Drugs for Allergic Rhinitis (online only)
The Medical Letter on Drugs and Therapeutics • Mar 31, 2025 (Issue 1725)
to
sales restrictions
Individual retailers may
have their own OTC generic
products
$20.006 ...
View the Comparison Table: Some Oral Drugs for Allergic Rhinitis
Med Lett Drugs Ther. 2025 Mar 31;67(1725):e55-7 doi:10.58347/tml.2025.1725b | Show Introduction Hide Introduction
Regorafenib (Stivarga) for Metastatic Colorectal Cancer and GIST (online only)
The Medical Letter on Drugs and Therapeutics • Apr 29, 2013 (Issue 1415)
. www.fdbhealth.com/policies/drug-pricing-policy. Actual
retail prices may vary.
Regorafenib (Stivarga ...
Regorafenib (Stivarga – Bayer), a multikinase inhibitor,
has been approved by the FDA for treatment of
patients with metastatic colorectal cancer previously
treated with multiple other regimens specified in the
labeling. It has also been approved for use in treatment-refractory, locally advanced, unresectable or
metastatic gastrointestinal stromal tumor (GIST).
Crofelemer (Fulyzaq) for Antiretroviral-Induced Diarrhea
The Medical Letter on Drugs and Therapeutics • Jul 22, 2013 (Issue 1421)
retail
prices may be higher.
antiretrovirals crofelemer Diarrhea Fulyzag HIV Imodium loperamide ...
The FDA has approved crofelemer (kroe fel’ e mer;
Fulyzaq – Salix), a chloride channel inhibitor derived
from the red sap of the South American plant Croton
lechleri, for symptomatic relief of noninfectious
diarrhea in patients with HIV taking antiretroviral
drugs. It is the first drug approved for relief of antiretroviral-induced diarrhea and the first oral botanical
drug approved by the FDA.
FDA Requires Lower Dosing of Zolpidem
The Medical Letter on Drugs and Therapeutics • Jan 21, 2013 (Issue 1408)
. All rights reserved. ©2012. www.fdbhealth.com/policies/drug-pricing-policy. Actual retail prices may vary.
2 ...
On January 10, 2013, the FDA issued a news release
to announce that it was requiring the manufacturers of
the zolpidem-containing products Ambien, Ambien
CR, Edluar and Zolpimist, which are all approved for
treatment of insomnia, to lower the doses for women
and to recommend in their labeling consideration of a
lower dose for men. No change will be required in the
dose of Intermezzo, a low-dose sublingual formulation
of zolpidem for middle-of-the-night awakening, which
is already recommended in a lower dose for women.
Ceritinib (Zykadia) for Non-Small Cell Lung Cancer
The Medical Letter on Drugs and Therapeutics • Jul 21, 2014 (Issue 1447)
. www.fdbhealth.com/policies/drug-pricingpolicy.
Actual retail price may be higher.
Zykadia Xalkori lung cancer ...
Ceritinib (Zykadia – Novartis), an oral tyrosine
kinase inhibitor, has received accelerated approval
from the FDA for treatment of patients with anaplastic
lymphoma kinase (ALK)-positive metastatic
non-small cell lung cancer (NSCLC) who have
progressed on or are intolerant to crizotinib (Xalkori).
It is the second tyrosine kinase inhibitor to be approved
for ALK-positive metastatic NSCLC; crizotinib was the
first. Translocations of the ALK gene are found in
about 5% of lung cancers; they occur predominantly
in nonsmokers with adenocarcinoma.
Comparison Chart: Some Drugs for Irritable Bowel Syndrome with Constipation (IBS-C) (online only)
The Medical Letter on Drugs and Therapeutics • Feb 03, 2025 (Issue 1721)
. Accessed January 12, 2025. Individual retailers may have their own generic products.
3. Dosage adjustments ...
View the Comparison Chart: Some Drugs for Irritable Bowel Syndrome with Constipation (IBS-C)
Med Lett Drugs Ther. 2025 Feb 3;67(1721):e1-3 doi:10.58347/tml.2025.1721e | Show Introduction Hide Introduction
Telaprevir (Incivek) and Boceprevir (Victrelis) for Chronic Hepatitis C
The Medical Letter on Drugs and Therapeutics • Jul 25, 2011 (Issue 1369)
. Average retail cost of 12 weeks’ treatment with telaprevir and 24 weeks’
treatment with boceprevir ...
Telaprevir (Incivek – Vertex) and boceprevir (Victrelis –
Merck) have been approved by the FDA for oral use in
combination with peginterferon and ribavirin for treatment
of chronic hepatitis C virus (HCV) genotype 1
infection in adults with compensated liver disease.
Both telaprevir and boceprevir were developed specifically
to inhibit the NS3/4A proteases that cleave HCV
encoded polyproteins of the genotype 1 virus.
Ocriplasmin (Jetrea) for Vitreomacular Adhesion
The Medical Letter on Drugs and Therapeutics • Aug 05, 2013 (Issue 1422)
. ©2013.
www.fdbhealth.com/policies/drug-pricing-policy. Actual retail
price may be higher.
Jetrea ...
Ocriplasmin (Jetrea – ThromboGenics) was recently
approved by the FDA as an intravitreal injection for treatment
of symptomatic vitreomacular adhesion. It is the
first drug to be approved in the US for this indication.
Electronic Cigarettes
The Medical Letter on Drugs and Therapeutics • Nov 11, 2013 (Issue 1429)
available in retail stores and on the Internet, their use
has been increasing over recent years, primarily ...
Electronic cigarettes, also called e-cigarettes, are advertised
as a safer, more convenient, and socially acceptable
alternative to smoking tobacco cigarettes. Widely
available in retail stores and on the Internet, their use
has been increasing over recent years, primarily among
smokers, but also among non-smokers.
NovolinPen for Insulin Injection
The Medical Letter on Drugs and Therapeutics • Dec 30, 1988 (Issue 782)
retail), and each PenNeedle costs about 10 cents. The 150-unit Novolin cartridges
cost $2.55 each ...
The NovolinPen (Squibb - Novo) is a device that uses prefilled cartridges to inject semisynthetic human insulin (Medical Letter, 25:63, 1983). Three formulations are available: regular insulin (Novolin R PenFill), NPH insulin isophane (Novolin N PenFill) and a mixture of 70% NPH and 30% regular (Novolin 70/30 PenFill). The NovolinPen is advertised as more accurate, more convenient and less expensive than conventional syringes and needles. The same device is marketed in Canada as the Novolin-Pen II (Connaught Novo). (An earlier device is also available as the Novolin-Pen in Canada and the...